Assistance to Pharmaceutical Industry for Common Facilities (APICF)

The limit of incentive will be 70% of the approved project cost or Rs 20 cr., whichever is less, as per approval of SSC. In the case of Himalayan States and States in the North East Region, the grant-in-aid would be Rs. 20 Crore per Cluster or 90% of the project cost of the Common Infrastructure Facilities (CIF), whichever is less.

A Central Sector Scheme for Assistance to Pharmaceutical Industry for Common Facilities. The Scheme would be implemented in a Public Private Partnership (PPP) mode through one time grant-in-aid to be released in various phases for creation of identified infrastructure and common facilities to a Special Purpose Vehicles (SPVs) set up for the purpose. The various aspects and outcomes of the Scheme will be reviewed after two years from the date of its initiation.

Assistance to Pharmaceutical Industry for Common Facilities (APICF) Objective Image

Objectives

Strengthening the existing infrastructure facilities in order to make Indian Pharma Industry a global leader in Pharma Sector.
Easy access to standard testing facilities and value addition in the domestic Pharma Industry, especially to SMEs through creation of common world class facilities for increased competitiveness.
To help industry meet the requirements of standards of environment at a reduced cost through innovative methods of common Waste Management System.
Exploit the benefits arising due to optimization of resources and economies of scale.

Benefits

The limit of incentive will be 70% of the approved project cost or Rs 20 cr., whichever is less, as per approval of SSC. In the case of Himalayan States and States in the North East Region, the grant-in-aid would be Rs. 20 Crore per Cluster or 90% of the project cost of the Common Infrastructure Facilities (CIF), whichever is less.

Assistance to Pharmaceutical Industry for Common Facilities (APICF) Benefit Image

Eligibility

The project will be implemented through a Special Purpose Vehicle (SPV) which will have a minimum of 3pharma units (including Bulk Drug and Medical Device Units) as its shareholders.
The SPV may have the representatives from cluster members, financial institutions, State and Central Government and R&D organizations. The SPV shall have full operational autonomy to develop, operate and maintain the infrastructure.
Pharma enterprises shall hold at least 51% equity of the SPV.
The combined net worth of members of SPV shall be equivalent to total grantamount applied for and each SPV member must have a net worth of at least 1.5 times of their proposed equity contribution.
The SPV members shall be legally independent entities without any related-party relationship with each other as described under Accounting Standard (AS) 18 of the Companies (Accounting Standard) Rules, 2006.

How to Apply?

It has been decided with the approval of Competent Authority to reopen the application window under the sub-scheme Assistance to Pharmaceutical Industry for Common Facilities' (API-CF) w.e.f. 11.12.2024 to 13.01.2025.

The interested applicants may apply through PMA (SIDBI) portal via online mode only. The Link is: https://spi.udyamimitra.in

The detailed API-CF guidelines dated 14.03.2024 are available on the Department's website at the link https: / / pharmaceuticals. gov. in / sites / default! files / Revised%2 guidelines% 2OSPI%20dated%2014.03.2024 0.pdf and on the PMA portal at the link https: / /spi.udyamimitra.in/ Schemes/ Operational Guidelines

Apply Now